Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.895 AUD | -12.25% | +5.29% | +37.69% |
May. 07 | EZZ Life Science Declares Fully Franked Interim Dividend | MT |
Apr. 26 | EZZ Life's Receipts from Customers Up 111% in Fiscal Q3 | MT |
Sales 2022 | 15.02M 10.05M | Sales 2023 | 37.16M 24.87M | Capitalization | 21.35M 14.29M |
---|---|---|---|---|---|
Net income 2022 | 1M 669K | Net income 2023 | 3M 2.01M | EV / Sales 2022 | 0.19 x |
Net cash position 2022 | 10.36M 6.93M | Net cash position 2023 | 13.35M 8.94M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
10
x | P/E ratio 2023 |
5.88
x | Employees | - |
Yield 2022 |
1.45% | Yield 2023 |
1.96% | Free-Float | 27.83% |
1 day | -12.25% | ||
1 week | +5.29% | ||
Current month | +0.56% | ||
1 month | +5.92% | ||
3 months | +72.12% | ||
6 months | +42.06% | ||
Current year | +37.69% |
Managers | Title | Age | Since |
---|---|---|---|
Qi Zhou Qin
FOU | Founder | - | 15-09-21 |
Anthony Guarna
DFI | Director of Finance/CFO | - | - |
Natalie Climo
SEC | Corporate Secretary | - | 20-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Cross
CHM | Chairman | - | 21-11-29 |
Ivan Oshry
BRD | Director/Board Member | - | 20-10-26 |
Qi Zhou Qin
FOU | Founder | - | 15-09-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.895 | -12.25% | 176,230 |
24-05-16 | 1.02 | -4.67% | 19,311 |
24-05-15 | 1.07 | +0.94% | 98,425 |
24-05-14 | 1.06 | +15.85% | 219,934 |
24-05-13 | 0.915 | +7.65% | 205,316 |
Delayed Quote Australian S.E., May 17, 2024 at 01:57 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.69% | 26.57M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- EZZ Stock